Literature DB >> 21858246

Polymeric vectors for ocular gene delivery.

Viral Tamboli1, Gyan P Mishra, Ashim K Mitrat.   

Abstract

Gene therapy holds promise for the treatment of many inherited and acquired diseases of the eye. Successful ocular gene therapy interventions depend on efficient gene transfer to targeted cells with minimal toxicity. A major challenge is to overcome both intracellular and extracellular barriers associated with ocular gene delivery. Numerous viral and nonviral vectors were explored to improve transfection efficiency. Among nonviral delivery systems, polymeric vectors have gained significant attention in recent years owing to their nontoxic and non-immunogenic nature. Polyplexes or nanoparticles can be prepared by interaction of cationic polymers with DNA, which facilitate cellular uptake, endolysosomal escape and nuclear entry through active mechanisms. Chemical modification of these polymers allows for the generation of flexible delivery vectors with desirable properties. In this article several synthetic and natural polymeric systems utilized for ocular gene delivery are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858246      PMCID: PMC3156448          DOI: 10.4155/tde.11.20

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  102 in total

Review 1.  Gene therapy for genetic and acquired retinal diseases.

Authors:  Edward Chaum; Mark P Hatton
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

Review 2.  Chitosan and its role in ocular therapeutics.

Authors:  Sheetu Wadhwa; Rishi Paliwal; Shivani Rai Paliwal; S P Vyas
Journal:  Mini Rev Med Chem       Date:  2009-12       Impact factor: 3.862

Review 3.  The biochemical structure of mammalian vitreous.

Authors:  P Bishop
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

4.  Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA.

Authors:  Y-K Oh; D Suh; J M Kim; H-G Choi; K Shin; J J Ko
Journal:  Gene Ther       Date:  2002-12       Impact factor: 5.250

Review 5.  Biodegradable polymers as non-viral carriers for plasmid DNA delivery.

Authors:  Jordy Luten; Cornelus F van Nostrum; Stefaan C De Smedt; Wim E Hennink
Journal:  J Control Release       Date:  2007-12-04       Impact factor: 9.776

6.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.

Authors:  J C Perales; T Ferkol; H Beegen; O D Ratnoff; R W Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Chitosan based nanocarriers for indomethacin ocular delivery.

Authors:  Alia A Badawi; Hanan M El-Laithy; Riad K El Qidra; Hala El Mofty; Mohamed El dally
Journal:  Arch Pharm Res       Date:  2008-09-12       Impact factor: 4.946

8.  Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.

Authors:  Oju Jeon; Hee-Won Lim; Minhyung Lee; Su Jin Song; Byung-Soo Kim
Journal:  J Drug Target       Date:  2007-04       Impact factor: 5.121

Review 9.  Prospects for gene therapy in corneal disease.

Authors:  A S Jun; D F P Larkin
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

Review 10.  Corneal gene therapy.

Authors:  Eytan A Klausner; Dan Peer; Robert L Chapman; Richard F Multack; Shridhar V Andurkar
Journal:  J Control Release       Date:  2007-07-04       Impact factor: 9.776

View more
  11 in total

1.  Nanoparticles in the ocular drug delivery.

Authors:  Hong-Yan Zhou; Ji-Long Hao; Shuang Wang; Yu Zheng; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

2.  A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina.

Authors:  Gustavo Puras Ochoa; Jon Zárate Sesma; Mireia Agirre Díez; Ariadna Díaz-Tahoces; Marcelino Avilés-Trigeros; Santiago Grijalvo; Ramón Eritja; Eduardo Fernández; Jose Luis Pedraz
Journal:  Pharm Res       Date:  2014-01-22       Impact factor: 4.200

Review 3.  Promising and delivering gene therapies for vision loss.

Authors:  Livia S Carvalho; Luk H Vandenberghe
Journal:  Vision Res       Date:  2014-08-02       Impact factor: 1.886

4.  Cationic polyene phospholipids as DNA carriers for ocular gene therapy.

Authors:  Susana Machado; Sofia Calado; Diogo Bitoque; Ana Vanessa Oliveira; Christer L Øpstad; Muhammad Zeeshan; Hans-Richard Sliwka; Vassilia Partali; Michael D Pungente; Gabriela A Silva
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

Review 5.  Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.

Authors:  Buddhadev Layek; Lindsey Lipp; Jagdish Singh
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

6.  Visual tracing of diffusion and biodistribution for amphiphilic cationic nanoparticles using photoacoustic imaging after ex vivo intravitreal injections.

Authors:  Xu Xu; Zhaokang Xu; Junyi Liu; Zhaoliang Zhang; Hao Chen; Xingyi Li; Shuai Shi
Journal:  Int J Nanomedicine       Date:  2016-10-05

Review 7.  Correction of Monogenic and Common Retinal Disorders with Gene Therapy.

Authors:  Jesse D Sengillo; Sally Justus; Thiago Cabral; Stephen H Tsang
Journal:  Genes (Basel)       Date:  2017-01-27       Impact factor: 4.096

Review 8.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

9.  One-step synthesis of gene carrier via gamma irradiation and its application in tumor gene therapy.

Authors:  Sung In Jeong; Seong-Cheol Park; Sun-Jeong Park; Eun-Ji Kim; Hun Heo; Jong-Seok Park; Hui-Jeong Gwon; Youn-Mook Lim; Mi-Kyeong Jang
Journal:  Int J Nanomedicine       Date:  2018-01-25

Review 10.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.